QSV Equity Investors LLC ASTH — ASTRANA HEALTH INC

Ownership history in QSV Equity Investors LLC  ·  8 quarters on record

AI Ownership Summary

QSV Equity Investors LLC reported ASTRANA HEALTH INC (ASTH) in 8 quarterly 13F filings from 2024 Q1 through 2025 Q4. Peak portfolio weight reached 1.61% in 2024 Q3. The latest visible filing shows ASTH at 1.09% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this ASTH ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was QSV Equity Investors LLC's position in ASTRANA HEALTH INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

ASTH was reported at 1.09% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.61% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

ASTH stock page QSV Equity Investors LLC fund profile QSV Equity Investors LLC full holdings
How QSV Equity Investors LLC held ASTH — position size vs. price
% of Fund (quarterly)    ASTH price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 24.5% -1.2% ✅ 29,786 -9,672 -24.5% 1.09% $739K 2026-02-14 (Est.) $18.78
2025 Q3 UNCHANGED — — — 39,458 — 0% 1.14% $1.1M 2025-11-14 $21.53
2025 Q2 REDUCED — — — 39,458 -328 -0.8% 1.02% $982K 2025-08-13 $29.63
2025 Q1 ADDED — — — 39,786 +10,190 +34.4% 1.28% $1.2M 2025-05-14 $26.50
2024 Q4 UNCHANGED — — — 29,596 — 0% 0.90% $933K 2025-02-12 $38.38
2024 Q3 UNCHANGED — — — 29,596 — 0% 1.61% $1.7M 2024-11-14 $41.90
2024 Q2 REDUCED — — — 29,596 -14 -0.0% 1.25% $1.2M 2024-08-14 $46.58
2024 Q1 INITIATED — — — 29,610 — — 1.20% $1.2M 2024-05-15 $41.18

🏢 Other funds also holding ASTH

As of 2026 Q1 — sorted by position size

325 CAPITAL LLC 3Y 16.43% 1492 Capital Management LLC 3Y 7Y 1.43% 683 Capital Management, LLC 3Y 7Y 0.9% Westmount Partners, LLC 0.47% SteelPeak Wealth, LLC 3Y 0.42% Insight Wealth Strategies, LLC 3Y 7Y 0.39% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.33% Integrated Quantitative Investments LLC 0.19% Emerald Investment Advisers, LLC 0.15% Linden Thomas Advisory Services, LLC 3Y 0.14%

FAQ About QSV Equity Investors LLC and ASTH

These are the practical questions this page is built to answer before you even open the full history table.

How long has QSV Equity Investors LLC reported owning ASTH?

QSV Equity Investors LLC reported ASTH across 8 quarterly 13F filings, from 2024 Q1 through 2025 Q4.

What was the largest reported ASTH position in QSV Equity Investors LLC's portfolio?

The largest reported portfolio weight for ASTH was 1.61% in 2024 Q3.

What is the latest reported ASTH position on this page?

The most recent filing on this page is 2025 Q4, when QSV Equity Investors LLC reported 29,786 shares, equal to 1.09% of portfolio, with an estimated market value of $739K.

What does the chart on this ASTH ownership page compare?

The chart compares QSV Equity Investors LLC's quarterly ASTH portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did QSV Equity Investors LLC time their ASTH position?

Based on 13F filing dates vs. subsequent ASTH price moves, QSV Equity Investors LLC correctly timed 4 out of 4 reported position changes (100%). The annualised alpha on ASTH relative to SPY over the holding period was -45.3%.

← Back to QSV Equity Investors LLC Holdings